Bill & Melinda Gates Foundation is of Atreca, Inc.. Currently has a direct ownership of 1.4 Million shares of BCEL, which is worth approximately $0. The most recent transaction as insider was on Jun 24, 2019, when has been sold 1,396,644 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.4M
0% 3M change
0% 12M change
Total Value Held $0

Bill & Melinda Gates Foundation Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2019
BUY
Conversion of derivative security
-
1,396,644 Added 50.0%
1,396,644 Class A Common Stock

Also insider at

VIR
Vir Biotechnology, Inc. Healthcare
XFOR
X4 Pharmaceuticals, Inc Healthcare
LQDA
Liquidia Technologies Inc
B&M

Bill & Melinda Gates Foundation

Seattle, WA

Track Institutional and Insider Activities on BCEL

Follow Atreca, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCEL shares.

Notify only if

Insider Trading

Get notified when an Atreca, Inc. insider buys or sells BCEL shares.

Notify only if

News

Receive news related to Atreca, Inc.

Track Activities on BCEL